Claritev Corporation (CTEV) Key Metrics
CTEV valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $374.9M
- Enterprise value
- $5.10B
- P/E (TTM)
- —
- Forward P/E
- 3.4
- PEG ratio
- —
- Price / sales
- 0.4 10-yr median 0.8
- Price / book
- 43.9 10-yr median 1.2
- EV / EBITDA
- 10.7 10-yr median 11.2
- Dividend yield
- —
- Beta
- 0.94
CTEV key metrics, 2018–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCTEV valuation Price multiples at each fiscal year-end price.
Price / sales+183.8%
0.7
2025 · hover or tap a bar for each year
20182025
EV / EBITDA
11.2
2025 · hover or tap a bar for each year
20182025
Free cash flow yield+2.7 pts
−1.7%
2025 · hover or tap a bar for each year
20182025
CTEV returns How much profit the business earns on the capital it uses.
Return on invested capital+21.1 pts
0.8%
2025 · hover or tap a bar for each year
20182025
Return on assets+21.5 pts
−5.7%
2025 · hover or tap a bar for each year
20182025
Free cash flow margin−0.1 pts
−1.3%
2025 · hover or tap a bar for each year
20182025
Asset turnover+25.2%
0.19
2025 · hover or tap a bar for each year
20182025
CTEV per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+1.9%
$58.74
2025 · hover or tap a bar for each year
20182025
Earnings per share
−$17.30
2025 · hover or tap a bar for each year
20182025
Free cash flow per share
−$0.75
2025 · hover or tap a bar for each year
20182025
Book value per share
−$10.58
2025 · hover or tap a bar for each year
20182025
Shares outstanding+1.8%
16.4M
2025 · hover or tap a bar for each year
20182025
CTEV financial health Debt, liquidity and how easily interest is covered.
Net debt+$91.1M
$4.62B
2025 · hover or tap a bar for each year
20182025
Net debt / EBITDA
9.71
2025 · hover or tap a bar for each year
20182025
Current ratio+4.6%
0.86
2025 · hover or tap a bar for each year
20182025
Interest coverage
0.1
2025 · hover or tap a bar for each year
20182025
Debt / assets+7.5%
0.95
2025 · hover or tap a bar for each year
20182025
CTEV efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding+9 days
47 days
2025 · hover or tap a bar for each year
20182025
Days payables outstanding−42 days
38 days
2025 · hover or tap a bar for each year
20182025
Cash conversion cycle+51 days
9 days
2025 · hover or tap a bar for each year
20182025
Capex / revenue+0.7 pts
13.4%
2025 · hover or tap a bar for each year
20182025
CTEV valuation history
Fiscal year-endToday8-year median
CTEV returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CTEV debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CTEV cash returned to shareholders
DividendsBuybacksFree cash flow
CTEV price vs earnings per share
Share price at year-endEPS (right axis)
CTEV key metrics
2018–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||
| Market capitalization | $702.6M | $238.7M | $929.0M | $734.8M | $2.89B | $3.76B | — | — |
| Enterprise value | $5.32B | $4.76B | $5.43B | $5.18B | $7.63B | $8.25B | — | — |
| P/E ratio | — | — | — | — | 28.3 | — | — | — |
| Price / sales | 0.7 | 0.3 | 1.0 | 0.7 | 2.6 | 4.0 | — | — |
| Price / book | — | 2.8 | 0.5 | 0.4 | 1.2 | 1.5 | — | — |
| Price / free cash flow | — | — | 14.8 | 2.6 | 9.0 | 12.3 | — | — |
| Price / operating cash flow | 6.0 | 2.2 | 5.4 | 2.0 | 7.1 | 10.0 | — | — |
| EV / sales | 5.5 | 5.1 | 5.6 | 4.8 | 6.8 | 8.8 | — | — |
| EV / EBITDA | 11.2 | — | 8.3 | 32.7 | 9.4 | 42.9 | — | — |
| EV / free cash flow | — | — | 86.3 | 18.3 | 23.8 | 26.9 | — | — |
| Earnings yield | −40.5% | −689.6% | −9.9% | −78.0% | 3.5% | −13.8% | — | — |
| Free cash flow yield | −1.7% | −4.4% | 6.8% | 38.5% | 11.1% | 8.1% | — | — |
| Shareholder yield (dividends + buybacks) | 0.0% | 4.3% | 1.6% | 13.6% | 3.5% | 2.7% | — | — |
| Share price at fiscal year-end | $42.75 | $14.78 | $57.60 | $46.00 | $177.20 | $319.60 | — | — |
| Per share | ||||||||
| Revenue per share | $58.74 | $57.63 | $59.62 | $67.60 | $68.61 | $79.68 | $35.74 | $37.85 |
| Earnings per share | −$17.30 | −$101.92 | −$5.69 | −$35.87 | $6.27 | −$44.23 | $0.35 | $1.32 |
| Operating cash flow per share | $7.14 | $6.66 | $10.65 | $23.31 | $24.85 | $32.06 | $10.34 | $10.63 |
| Free cash flow per share | −$0.75 | −$0.65 | $3.90 | $17.69 | $19.65 | $26.05 | $7.92 | $8.32 |
| Cash per share | $1.02 | $1.04 | $4.44 | $20.91 | $11.38 | $10.77 | $0.79 | — |
| Book value per share | −$10.58 | $5.20 | $105.97 | $112.10 | $143.95 | $217.33 | $72.19 | — |
| Tangible book value per share | −$271.64 | −$281.49 | −$294.70 | −$303.94 | −$325.60 | −$448.92 | −$219.76 | — |
| Capex per share | $7.89 | $7.32 | $6.75 | $5.62 | $5.19 | $6.02 | $2.42 | $2.31 |
| Debt per share | $281.86 | $281.22 | $283.22 | $299.40 | $302.43 | $391.89 | $197.44 | — |
| Shares outstanding | 16.4M | 16.1M | 16.1M | 16.0M | 16.3M | 11.8M | 27.5M | 27.5M |
| Change in shares outstanding | +1.8% | +0.1% | +1.0% | −1.9% | +38.4% | −57.2% | 0.0% | — |
| Returns & profitability | ||||||||
| Return on equity (ROE) | — | −183.6% | −5.2% | −27.7% | 4.2% | −22.9% | 0.5% | — |
| Return on invested capital (ROIC) | 0.8% | −20.3% | 2.1% | −4.3% | 4.1% | −1.4% | 4.6% | — |
| Return on assets (ROA) | −5.7% | −27.2% | −1.3% | −7.3% | 1.2% | −6.3% | 0.1% | — |
| Return on tangible assets | −47.5% | −315.7% | −18.2% | −78.9% | 17.8% | −117.8% | 2.9% | — |
| Free cash flow margin | −1.3% | −1.1% | 6.5% | 26.2% | 28.6% | 32.7% | 22.2% | 22.0% |
| Income quality (OCF / net income) | — | — | — | — | 3.96 | — | 29.28 | 8.07 |
| Financial health | ||||||||
| Total debt | $4.63B | $4.54B | $4.57B | $4.78B | $4.93B | $4.61B | $5.43B | — |
| Cash & short-term investments | $16.8M | $16.8M | $71.5M | $334.0M | $185.3M | $126.8M | $21.8M | — |
| Net debt | $4.62B | $4.52B | $4.50B | $4.45B | $4.74B | $4.49B | $5.41B | — |
| Debt / equity | — | 54.05 | 2.67 | 2.67 | 2.10 | 1.80 | 2.74 | — |
| Debt / assets | 0.95 | 0.88 | 0.66 | 0.65 | 0.60 | 0.56 | 0.65 | — |
| Net debt / EBITDA | 9.71 | — | 6.90 | 28.10 | 5.82 | 23.31 | 6.88 | — |
| Current ratio | 0.86 | 0.82 | 1.16 | 2.54 | 2.25 | 1.86 | 1.35 | — |
| Quick ratio | 0.86 | 0.82 | 1.16 | 2.54 | 2.25 | 1.86 | 1.35 | — |
| Interest coverage | 0.1 | -4.3 | 0.5 | -1.2 | 1.4 | -0.4 | 1.0 | 1.1 |
| Working capital | −$37.0M | −$38.3M | $26.9M | $270.9M | $177.3M | $96.4M | $29.8M | — |
| Invested capital | $4.44B | $4.61B | $6.21B | $6.24B | $7.09B | $7.04B | $7.39B | — |
| Tangible asset value | −$4.46B | −$4.55B | −$4.75B | −$4.85B | −$5.30B | −$5.28B | −$6.04B | — |
| Net current asset value | −$4.83B | −$4.89B | −$5.06B | −$5.13B | −$5.56B | −$5.52B | −$6.26B | — |
| Graham number | — | — | — | — | $142.47 | — | $23.95 | — |
| Graham net-net per share | −$300.29 | −$307.55 | −$317.48 | −$324.75 | −$344.76 | −$471.69 | −$228.93 | — |
| Capital allocation | ||||||||
| Share buybacks (net) | $0 | $10.4M | $15.2M | $100.0M | $100.0M | $101.1M | — | — |
| Dividends + buybacks / free cash flow | — | — | 24.2% | 35.4% | 31.2% | 33.0% | — | — |
| Capex / revenue | 13.4% | 12.7% | 11.3% | 8.3% | 7.6% | 7.6% | 6.8% | 6.1% |
| Capex / operating cash flow | 110.5% | 109.8% | 63.4% | 24.1% | 20.9% | 18.8% | 23.4% | 21.7% |
| Capex / depreciation | 0.29 | 0.27 | 0.26 | 0.22 | 0.21 | 0.18 | 0.17 | 0.16 |
| Stock-based compensation / revenue | 2.9% | 2.9% | 1.9% | 1.6% | 1.6% | 43.3% | −1.5% | 0.5% |
| SG&A / revenue | 22.9% | 17.2% | 14.1% | 12.2% | 13.5% | 37.9% | 7.7% | 7.5% |
| Efficiency | ||||||||
| Days sales outstanding | 47.2 | 38.5 | 31.1 | 30.2 | 26.6 | 27.3 | 28.6 | — |
| Days payables outstanding | 38.3 | 80.7 | 25.5 | 23.5 | 29.4 | 14.2 | 23.3 | — |
| Cash conversion cycle (days) | 8.9 | -42.2 | 5.6 | 6.7 | -2.8 | 13.1 | 5.3 | — |
| Receivables turnover | 7.73 | 9.48 | 11.75 | 12.08 | 13.70 | 13.37 | 12.75 | — |
| Payables turnover | 9.52 | 4.52 | 14.32 | 15.52 | 12.40 | 25.67 | 15.64 | — |
| Asset turnover | 0.19 | 0.15 | 0.13 | 0.14 | 0.14 | 0.11 | 0.12 | — |
| Average receivables | $124.9M | $98.2M | $81.8M | $89.4M | $81.6M | $70.1M | $77.1M | — |
| Average payables | $73.4M | $53.0M | $16.4M | $13.2M | $14.1M | $12.4M | $9.6M | — |
| Intangibles / total assets | 87.8% | 89.9% | 92.8% | 90.2% | 93.0% | 94.7% | 96.0% | — |
Computed from CTEV's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CTEV valuation and financial ratios
Claritev earned a return on invested capital of 0.8% in fiscal 2025. It ended the year with $4.6 billion of debt and $16.8 million in cash and short-term investments, net debt of $4.6 billion. The share count fell 40.2% from 27.5M to 16.4M over 7 years.
See the CTEV income statement, the CTEV chart for price history, or the CTEV stock overview for the latest quote and news.
CTEV key metrics FAQ
What is Claritev's EV/EBITDA?
Claritev's enterprise value was 11.2 times EBITDA at the end of fiscal 2025 (enterprise value $5.3 billion, EBITDA $475.4 million); the current EV/EBITDA is 10.7.
What is Claritev's ROIC?
Claritev's return on invested capital was 0.8% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Claritev have?
Claritev had total debt of $4.6 billion at the end of fiscal 2025 and $4.6 billion of net debt (9.71 times EBITDA).
What is Claritev's free cash flow yield?
Claritev generated -$12.3 million of free cash flow in fiscal 2025, a free cash flow yield of −1.7% on its market value at year-end ($702.6 million).
What is Claritev's current ratio?
Claritev's current ratio was 0.86 at the end of fiscal 2025: current assets were 0.86 times current liabilities.